Renal Transporter Alterations in Patients with Chronic Liver Diseases: Nonalcoholic Steatohepatitis, Alcohol-Associated, Viral Hepatitis, and Alcohol-Viral Combination-Reference-Cited by-同舟云学术

Renal Transporter Alterations in Patients with Chronic Liver Diseases: Nonalcoholic Steatohepatitis, Alcohol-Associated, Viral Hepatitis, and Alcohol-Viral Combination

Published:2022-11-03 Issue:2 Volume:51 Page:155-164
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Frost Kayla L.,Jilek Joseph L.^ORCID,Sinari Shripad,Klein Robert R.,Billheimer Dean,Wright Stephen H.,Cherrington Nathan J.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference30 articles.

1. Renal glomerular lesions in unselected patients with cirrhosis undergoing orthotopic liver transplantation

2. GFR Estimating Equations and Liver Disease

3. Proton Pump Inhibitors Inhibit Methotrexate Transport by Renal Basolateral Organic Anion Transporter hOAT3

4. Extrahepatic Drug Transporters in Liver Failure: Focus on Kidney and Gastrointestinal Tract;Droździk;Int J Mol Sci,2020

5. Organic Anion Transporters and Their Implications in Pharmacotherapy

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug transporters in drug disposition – highlights from the year 2023;Drug Metabolism Reviews;2024-09-11

2. Innovations, Opportunities, and Challenges for Predicting Alteration in Drug-Metabolizing Enzyme and Transporter Activity in Specific Populations;Drug Metabolism and Disposition;2023-09-29

3. A Newly Developed Method-Based Xanthine Oxidoreductase Activities in Various Human Liver Diseases;Biomedicines;2023-05-14

4. Representative Rodent Models for Renal Transporter Alterations in Human Nonalcoholic Steatohepatitis;Drug Metabolism and Disposition;2023-05-03